-
1
Study investigates reuse of COVID-19 blood samples for leprosy detection.
-
2
Identified 12 undiagnosed leprosy cases in Brazil.
-
3
New antibody markers against Mycobacterium leprae performed better than PGL-I.
-
4
Integrating symptom questionnaires with serology improves sensitivity.
-
5
Widespread leprosy transmission indicated, requiring broader screening.
-
6
Highlights importance of existing sample collections for disease surveillance.
Original Source(s)
Related Content
Viral, Fungal Infections May Contribute to Nonresolving ARDS
Review links viral and fungal infections to persistent lung injury in nonresolving ARDS
by Kerri Miller
April 16, 2026
-
6 min
Hidden Parasite Spreads to Washington
Findings in coyotes signal new challenges for diagnostics and surveillance
April 16, 2026
-
2 min
Jonathan Van-Tam on COVID’s Next Phase
Former UK Deputy Chief Medical Officer discusses new protein-based vaccines, declining uptake, and the ongoing risks of COVID-19
April 14, 2026
-
7 min
